Prophylactic and Therapeutic Targeting of the Neurokinin-1 Receptor Limits Neuroinflammation in a Murine Model of Pneumococcal Meningitis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Immunology

• Publication date

  2011-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1100721PMID 21562162PMCID PMC3110637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Streptococcus pneumoniae

  2020cited by this paper
• Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier

  2010cited by this paper
• Neurokinin-1 receptor antagonists: a comprehensive patent survey

  2010cited by this paper
• Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.

  2010cited by this paper
• NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae

  2010cited by this paper
• NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens

  2009cited by this paper
• Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism

  2009cited by this paper
• Neurogenic Exacerbation of Microglial and Astrocyte Responses to Neisseria meningitidis and Borrelia burgdorferi1

  2008cited by this paper
• Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism

  2008cited by this paper
• Role of neuropeptides in inflammatory bowel disease

  2007cited by this paper
• Bacterial Infections of the Central Nervous System: A Critical Role for Resident Glial Cells in the Initiation and Progression of Inflammation

  2007cited by this paper
• The role of Toll‐like receptors in CNS response to microbial challenge

  2006cited by this paper
• Murine glia express the immunosuppressive cytokine, interleukin‐10, following exposure to Borrelia burgdorferi or Neisseria meningitidis

  2006cited by this paper
• Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?

  2004cited by this paper
• Assessment of Spatial Memory Using the Radial Arm Maze and Morris Water Maze

  2004cited by this paper
• The role of tachykinins in central nervous system inflammatory responses.

  2004cited by this paper
• A Murine Model for Neuropsychiatric Disorders Associated with Group A β-Hemolytic Streptococcal Infection

  2004cited by this paper
• Substance P Augments Borrelia burgdorferi-Induced Prostaglandin E2 Production by Murine Microglia1

  2004cited by this paper
• Impaired spatial learning after hypergravity exposure in rats.

  2004cited by this paper
• Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.

  2003cited by this paper
• Soluble Factors Released by Toxoplasma gondii-Infected Astrocytes Down-Modulate Nitric Oxide Production by Gamma Interferon-Activated Microglia and Prevent Neuronal Degeneration

  2003cited by this paper
• Reduced CTL Response and Increased Viral Burden in Substance P Receptor-Deficient Mice Infected with Murine γ-Herpesvirus 681

  2003cited by this paper
• Toll‐like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram‐positive bacterium Staphylococcus aureus

  2003cited by this paper
• Neuropharmacological sequelae of persistent CNS viral infections: lessons from Borna disease virus.

  2003cited by this paper
• Expression of functional NK‐1 receptors in murine microglia

  2002cited by this paper
• Interferon‐γ differentially modulates the release of cytokines and chemokines in lipopolysaccharide‐ and pneumococcal cell wall‐stimulated mouse microglia and macrophages

  2002cited by this paper
• Expression and regulation of interleukin‐10 and interleukin‐10 receptor in rat astroglial and microglial cells

  2002cited by this paper
• Long-term follow-up of children with bacterial meningitis with emphasis on behavioural characteristics

  2002cited by this paper
• Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury.

  2002cited by this paper
• Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae

  2002cited by this paper
• Flow Cytometric Analysis of Inflammatory Cells in Ischemic Rat Brain

  2002cited by this paper
• Substance P receptor mediated macrophage responses.

  2001cited by this paper
• Local immune regulation in the central nervous system by substance P vs. glutamate.

  2001cited by this paper
• Effects of Microenvironment on Morphology and Function of the Microglial Cell Line BV-2

  2001cited by this paper
• Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats.

  2001cited by this paper
• The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni.

  1999cited by this paper
• Current Protocols In Neuroscience

  1999cited by this paper
• Substance P Diminishes Lipopolysaccharide and Interferon-γ-Induced TGF-β1 Production by Cultured Murine Macrophages

  1998cited by this paper
• Substance P diminishes lipopolysaccharide and interferon-gamma-induced TGF-beta 1 production by cultured murine macrophages.

  1998cited by this paper
• Functional characterization of substance P receptors on cultured human spinal cord astrocytes: Synergism of substance P with cytokines in inducing interleukin‐6 and prostaglandin E2 production

  1997cited by this paper
• Possible different mechanism between amyloid-beta (25-35)-and substance P-induced chemotaxis of murine microglia.

  1997cited by this paper
• The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells.

  1997cited by this paper
• Neurogenic Amplification of Immune Complex Inflammation

  1996cited by this paper
• Recognition of neurokinin 1 receptor (NK1-R): an antibody to a peptide sequence from the third extracellular region binds to brain NK1-R.

  1996cited by this paper
• Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide.

  1994cited by this paper
• Interleukin-6 secretion from human astrocytoma cells induced by substance P.

  1994cited by this paper
• Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.

  1992cited by this paper
• Substance P stimulates IL-1 production by astrocytes via intracellular calcium.

  1992cited by this paper
• Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism

  1988cited by this paper

• Substance P Augments Chemokine Production by Staphylococcus aureus Infected Murine Osteoclasts

  2025cites this paper
• Evidence for the Involvement of the Tachykinin NK1 Receptor in Acute Inflammation of the Central Nervous System

  2023cites this paper
• Substance P Exacerbates the Inflammatory and Pro-osteoclastogenic Responses of Murine Osteoclasts and Osteoblasts to Staphylococcus aureus

  2022cites this paper
• Contribution of protein-derived bioactive molecules (cytokines and chemokines) in neuroinflammation, resolution, and neuroprotection

  2022cites this paper
• Substance P—Friend or Foe

  2022cites this paper
• Biomarkers and Their Possible Functions in the Intestinal Microenvironment of Chagasic Megacolon: An Overview of the (Neuro)inflammatory Process

  2021cites this paper
• Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis

  2021cites this paper
• Retinoic acid inducible gene-I mediated detection of bacterial nucleic acids in human microglial cells

  2020cites this paper
• NOD2 regulates microglial inflammation through the TAK1-NF-κB pathway and autophagy activation in murine pneumococcal meningitis.

  2020cites this paper
• Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study.

  2020cites this paper
• Crossing the Blood-Brain Barrier by Neuroinvasive Pathogens

  2018cites this paper
• Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation

  2018cites this paper
• Tropisetron attenuates lipopolysaccharide induced neuroinflammation by inhibiting NF-κB and SP/NK1R signaling pathway.

  2018cites this paper
• The Interleukin-10 Family of Cytokines and Their Role in the CNS

  2018cites this paper
• Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis

  2017cites this paper
• Neuro-Immune Mechanisms of Anti-Cryptococcal Protection

  2017cites this paper
• Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis

  2017cites this paper
• Homeostasis Inflammation , Wound Healing , and Tissue Role of Substance P Neuropeptide in Susmit Suvas

  2017cites this paper
• Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P

  2017cites this paper
• The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders

  2017influential citation
• Translational potential of astrocytes in brain disorders.

  2016cites this paper
• Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

  2016cites this paper
• Transmission pathways and mediators as the basis for clinical pharmacology of pain

  2016cites this paper
• Investigating the role of MRGPRC11 and capsaicin-sensitive afferent nerves in the anti-influenza effects exerted by SLIGRL-amide in murine airways

  2016cites this paper
• Neuroglia in Infectious Brain Diseases

  2015cites this paper
• Substance P and the regulation of inflammation in infections and inflammatory bowel disease

  2015cites this paper
• Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis

  2015cites this paper
• Analysis of nucleotide-binding oligomerization domain proteins in a murine model of pneumococcal meningitis

  2014cites this paper
• Involvement of substance P and the NK-1 receptor in human pathology

  2014influential citation
• Substance P Exacerbates Dopaminergic Neurodegeneration through Neurokinin-1 Receptor-Independent Activation of Microglial NADPH Oxidase

  2014cites this paper
• Neuroimmune pathways in alcohol consumption: evidence from behavioral and genetic studies in rodents and humans.

  2014cites this paper
• Tachykinin: recent developments and novel roles in health and disease

  2014cites this paper
• Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.

  2013cites this paper
• Substance P participates in immune-mediated hepatic injury induced by concanavalin A in mice and stimulates cytokine synthesis in Kupffer cells

  2013cites this paper
• Blocking Neurogenic Inflammation for the Treatment of Acute Disorders of the Central Nervous System

  2013cites this paper
• Substance P and the host immune response

  2012cites this paper
• Substance P Affects Growth Factors in Pseudomonas aeruginosa–Infected Mouse Cornea

  2012cites this paper
• Treatment of bacterial meningitis: an update

  2012cites this paper